Opinion: FDA calls states’ bluffs on drug importation
For decades, critics of the U.S. drug pricing system have advocated importing drugs from Canada…
Category: drug pricing
STAT Plus: A city in Georgia is the latest to sue Mallinckrodt over its pricey Acthar Gel medicine
The city of Marietta, Ga., has joined a growing list of unions and local governments…
STAT Plus: Americans with employer coverage saw growth in drug spending outpace other medical costs
Americans with private employer health insurance spent nearly 26% more on prescription drugs from 2014…
.jpg)
STAT Plus: Insulin makers object to FDA proposal for speeding arrival of biosimilar insulins
Amid growing rancor over the cost of insulin, two of the largest manufacturers are objecting…
STAT Plus: After a new version of a decades-old drug gets orphan status, the price suddenly skyrockets
For years, hospitals and clinics have used an injectable medicine called dehydrated alcohol to treat…
STAT Plus: Pharmalittle: Trump considers executive action to cut drug prices; feds ‘not done’ with generic price-fixing probe
Rise and shine, everyone, another busy day is on the way. We can tell because…
In reelection bid, a GOP lawmaker campaigns on Pelosi’s drug pricing bill
WASHINGTON — In the months before House Democrats passed their aggressive drug negotiation bill, GOP…
In their words: Warren, Buttigieg, Klobuchar, and other Democrats explain exactly how they’d lower drug prices
Every single Democratic presidential candidate agrees that the federal government should take a far more…
STAT Plus: A closer look at Bernie Sanders’ plans to upend pharma and lower drug prices
The following is an excerpt from STAT’s deep dive report into the Democrats running for…
STAT Plus: U.S. officials lash out at the Dutch government for moves that ‘undermine’ pharma patent rights
In an unusual move, the U.S. Embassy in the Netherlands is taking the Dutch government…
STAT Plus: A closer look at Pete Buttigieg’s aggressive, wonky plan to lower drug prices
The following is an excerpt from STAT’s deep dive report into the Democrats running for…
Democrats interrupted Trump’s State of the Union to chant about their drug pricing bill
WASHINGTON — President Trump’s brief remarks on drug pricing during Tuesday’s State of the Union…
STAT Plus: A former Taro Pharma executive is indicted in generic price-fixing probe
A former senior executive at Taro Pharmaceuticals USA was indicted for his role in a…
STAT Plus: Pharma execs argue new Canadian regulations for setting drug prices will hurt the country
As Canada gets set to implement new regulations designed to cut prescription drug spending, the…
STAT Plus: FDA and FTC vow to attack anti-competitive practices that limit biosimilar uptake
As frustration mounts over the slower-than-expected uptake of biosimilars in the marketplace, two U.S. federal…
STAT Plus: Pharmalittle: France indicts Sanofi over epilepsy drug risks; Trump talk of drug pricing in SOTU speech may backfire
Hello, everyone, and how are you today? We are doing just fine, thank you, despite…
More than a dozen Democrats are bringing people with sky-high insulin bills to the State of the Union
WASHINGTON — From the farmlands of Illinois to Florida’s Gulf Coast, insulin affordability advocates have…
.jpg)
STAT Plus: If Medicare negotiated insulin prices like the VA, it could have saved billions
As insulin becomes a poster child for the growing outcry over the cost of medicines,…
STAT Plus: Employers shoulder plenty of drug costs, but haven’t lobbied much to lower them — until now
WASHINGTON — Companies like Pepsi, Walmart, and Jack in the Box foot the bill for…
STAT Plus: PBMs favor their own pharmacies in the Florida Medicaid program
As angst rises over the prices paid for medicines, a new analysis finds some pharmacy…
STAT Plus: Trump’s Medicaid changes offers states new powers to lower drug costs — with a catch
WASHINGTON — The Trump administration on Thursday unveiled a powerful new tool for states to…
Listen: A chemist breaks bad, the latest on the coronavirus, and pharma’s slow Bern
Is it wise to lie to the feds? Is pharma taking Sen. Bernie Sanders seriously?…
STAT Plus: U.S. officials will let Novartis pay expenses for some Kymriah patients who must travel for treatment
In an unexpected move, the Department of Health and Human Services will allow Novartis (NVS)…
Opinion: Biotech can — and must — reshape the pricing debate and protect future innovation
The week before the craziness known as J.P. Morgan 2020 began, more than 300 biotech…
STAT Plus: Pharmalittle: Insulin dominates Democrats’ health agenda in Iowa; FDA studies Instagram influencers
Good morning, everyone. The world is watching China, the new coronavirus, and the outbreak’s spread….
It’s the insulin, stupid: How drug pricing’s simplest case study became a top issue for 2020 Democrats
WATERLOO, Iowa — Presidential candidates can’t stop talking about insulin. At a campaign stop here…
Martin Shkreli is sued by the FTC and NY attorney general for illegally cornering a market
More than four years after Martin Shkreli incensed Americans by raising the price of a…
STAT Plus: Big drug purchasers predict price hikes driven by expensive new therapies
More than two dozen big buyers of prescription medicines expect that prices will rise by…
STAT Plus: Roche is fined by Romania for thwarting competition to its cancer medicines
Following a two-year investigation, Roche (RHHBY) was fined $14 million by antitrust authorities in Romania…
STAT Plus: Another patient charity settles charges it helped drug makers pay Medicare kickbacks
After a contentious, two-year battle with federal authorities, a patient charity called Patient Services agreed…
Want to know how contentious drug pricing is in Washington? Check the receipts
WASHINGTON — Pfizer, Johnson & Johnson, Merck and the 31 other major drug makers that…
STAT Plus: Civica Rx teams with Blue Cross Blue Shield to widen its alternative market for generics
In its latest bid to rework the marketplace for generic drugs, the Civica Rx nonprofit…
STAT Plus: Lilly exec says ‘there are no villains’ in the high-priced insulin market
Several months ago, Eli Lilly (LLY) launched LisPro, an authorized generic version of its Humalog…
STAT Plus: Pharmalittle: Roche plans aggressive SMA drug pricing; where are those clinical trial results?
Good morning. Elizabeth Cooney here in Boston while Ed Silverman hobnobs with industry types at…
STAT Plus: Pharmalittle: AstraZeneca fish oil pill flops; boom in biopharma dealmaking predicted for 2020
Good morning. Elizabeth Cooney sitting in for Ed Silverman, who is covering the J.P. Morgan…
High cost of multiple sclerosis medicines is forcing many patients to take ‘drastic actions’
The high cost of multiple sclerosis treatments has forced 40% of patients to take “drastic…
A ‘radical proposition’: A health care veteran tries to upend the system and bring drug prices down
The U.S. health system could get some relief from rising drug prices from an unlikely…
STAT Plus: Supreme Court will review an Arkansas law governing pharmacy benefit managers
In a move with the potential to affect health care costs, the U.S. Supreme Court…
STAT Plus: Pharmalittle: Execs vow to place patients ahead of profits; conservatives like Republican drug pricing bill
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
Conservative group with pharma ties makes clear there are drug pricing reforms they can support
WASHINGTON — The conservative American Action Network launched a $4 million advertising campaign Tuesday to…
STAT Plus: Generic makers will appeal ruling that allows California to proceed with law banning pay-to-delay deals
A federal judge dealt the pharmaceutical industry a setback by declining to block a new…
STAT Plus: It’s ‘business as usual’ as many drug makers boost prices for the new year
A new year often means higher prices for prescription medicines and 2020 is no exception….
STAT Plus: Pharmalittle: FDA failed to police opioid prescribing program; Novo launches plan to mitigate insulin cost
Good morning, everyone, and welcome to a new year. We hope the extended respite —…
3 drug pricing policy experiments to watch in 2020
WASHINGTON — Politicians spent the better part of 2019 bickering over the best way to…
3 congressional races to watch in 2020
WASHINGTON — Drug prices are on the ballot once again in 2020. It’s already evident…
2019 was supposed to be the year Washington lowered drug prices. What happened?
WASHINGTON — Lawmakers of all stripes made an agreement the day following the midterm elections…
STAT Plus: As families in Europe clamor for its pricey gene therapy, Novartis creates a lottery
Seeking to provide its pricey gene therapy to patients in countries where the drug is…
STAT Plus: One drug maker has a lot more to lose than others, under early drafts of drug importation plans
WASHINGTON — President Trump’s plan to let states and drug wholesalers import medicines from Canada…
Top Republican blasts McConnell for derailing bipartisan drug pricing bill
WASHINGTON — Sens. Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.), the bipartisan duo behind the…
STAT Plus: Feds says a CVS long-term-care pharmacy improperly refilled prescriptions, jeopardizing patients
Omnicare, the nation’s largest long-term-care pharmacy, was accused by federal authorities of fraudulently billing government…